Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Have a great weekend all, absolutely stunning weather, I’ve got mild 2/10 hangover. I’m looking forward to spending lots of time out in the sun.
The plan is to glance at price at 4:30pm and then be back here 8am Monday.
100 percent agree, it’s time for a beer, taxi is on its way. Tomorrow not necessarily the day but let’s put it this way, we don’t even need to speculate how long we will need for news. COPD in August and something is going to come out following on from the mind blowing hospital data.
Back to the beer, I have started to take a 6oz hip flask filled with some of my finest whiskey to the pub, partially due to me been tight but more so because the pub has an awful whiskey collection.
Have a great evening. I will either watch the Snooker or Europa tonight.
Pun intended (wink)
The 147 by Higgins in snooker, fantastic to see a legend, rolling back the year.
Also, to get back on topic, as it has been my speciality, I wouldn’t want to be out of this, this weekend.
https://youtu.be/npEFq4AiuIY
The video is pre the hospital trial results.
Just my random musings from it.
In regards to the home trial, Richard rephrased from happy to delighted about the improved efficiency of NHS testing with a quicker turnaround in results for Covid diagnosis. He was already talking about local clusters and as we can see now, local clusters are being picked up quickly via the testing, I’m hopeful that home trial will be completed.
Pre results, as the interviewer suggested, there was a notion that home results would be better than hospital due to the earlier the drug being given the better. I’m trying to imagine home results being better than hospital!
Coronavirus was a call to action for Synairgen and Richard talks about trying set up trials in China and Italy before eventually starting the trial in England. For me, this bodes well for trials in other countries going forward (if needed).
A small note, Woodford at his peak holding, held 20% of SNG. Not sure if that is positive or negative but worth noting.
COPD trial was already funded. The funding a few months ago for £14m funds hospital, home and the supply chain.
The interviewer pressed Richard on whether more funding required. Richard said he couldn’t say yes or no but went on to say, we need to see the strength of the data. Well we now know how strong the data is.
Richard goes on to say the strategy has ALWAYS been to either forge partnership or transact with large company.
He then says Synairgen and in position currently to take away risks first to enhance the value of the asset. He talks about data and approvals. For this we can gauge the route the company want to take.
All comments are my own interpretation of the video. I would recommend investors watch or rewatch this video. It only has 2.5k views.
The train has left the station. Choo choo
For clarity and transparency, I do not work for Landsdowne or any of their affiliations.
ATB
Well, I couldn’t imagine today’s rise if they were still selling. That would actually be more encouraging if they were selling and we made the rise today!!!! IMO they’ve stopped.
Today’s SP action suggests they have finished selling. This is now ready for take off. The foot has moved off the brake pedal.
It’s only the 5th of August. It’s time to relax.
Los resultados preliminares de un ensayo clínico sugieren que un nuevo tratamiento para Covid-19 reduce la cantidad de pacientes que necesitan cuidados intensivos, según la compañía del Reino Unido que lo desarrolló. El tratamiento de Synairgen.
LOL the sheep in hospitals having been doing it for years, some have been wearing face nappies for 8 hour shifts!!! They must be the most deluded, much more so than the lad that chicks one on for 10 mins to pick up some special brew.
I’m expecting peer review and COPD results as a minimum this month. Wouldn’t be surprised by regulators and agencies approvals. Transacting with a big pharma not out of the question, this month either.
Climbing. May get to 95p soonish.
You would hope so.
Shares get converted. You most certainly don’t want to be out before a buy out/takeover.
Throw in holdings RNSs you can drop it to 4-1
Hargreaves Lansdown has added Amati UK Smaller Companies, a top-performing fund backing Covid vaccine developer Synairgen, to its Wealth Shortlist. This is the first addition since online stockbroker overhauled its funds buy list in June.
Below is what Amati fund had to say about Synairgen in July
http://citywire.co.uk/funds-insider/news/star-small-cap-investor-hails-truly-fantastic-virus-drug-trial/a1382443
https://twitter.com/fundfanatic/status/1290321771103760384?s=21
Nice read.